Alnylam Pharmaceuticals (ALNY) Insider Trading & Ownership → Do This Before July 30 2024 To Claim Trump’s Gift (From Wealthpin Pro) (Ad) Free ALNY Stock Alerts $148.43 -1.60 (-1.07%) (As of 05/31/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Alnylam Pharmaceuticals (NASDAQ:ALNY) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$11.88 M Get ALNY Insider Trade Alerts Want to know when executives and insiders are buying or selling Alnylam Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ALNY Insider Buying and Selling by Quarter Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Alnylam Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/29/2024Amy W SchulmanDirectorSell21,700$148.60$3,224,620.00 1/29/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$180.96$1,001 - $15,0001/11/2024Josh GottheimerU.S. Congress Member (D-NJ)Buy$195.08$1,001 - $15,00012/27/2023Michael W BonneyDirectorSell30,000$195.00$5,850,000.00 12/11/2023Josh GottheimerU.S. Congress Member (D-NJ)Sell$170.92$1,001 - $15,0008/7/2023Pushkal GargCMOSell4,166$183.89$766,085.74 8/4/2023Jeffrey V PoultonCFOSell3,460$185.85$643,041.00 8/4/2023Pushkal GargCMOSell3,461$185.85$643,226.85 8/4/2023Yvonne GreenstreetCEOSell4,057$185.85$753,993.45 (Data available from 1/1/2013 forward) ALNY Insider Trading Activity - Frequently Asked Questions Who is on Alnylam Pharmaceuticals's Insider Roster? The list of insiders at Alnylam Pharmaceuticals includes Akshay Vaishnaw, Amy W Schulman, Indrani Lall Franchini, Jeffrey V Poulton, John Maraganore, Laurie Keating, Michael W Bonney, Pushkal Garg, Steven M Paul, Tolga Tanguler, and Yvonne Greenstreet. Learn more on insiders at ALNY. What percentage of Alnylam Pharmaceuticals stock is owned by insiders? 1.50% of Alnylam Pharmaceuticals stock is owned by insiders. Learn more on ALNY's insider holdings. Which Alnylam Pharmaceuticals insiders have been selling company stock? The following insiders have sold ALNY shares in the last 24 months: Akshay Vaishnaw ($465,459.28), Amy W Schulman ($3,224,620.00), Indrani Lall Franchini ($1,113,566.75), Jeffrey V Poulton ($833,155.43), Michael W Bonney ($5,850,000.00), Pushkal Garg ($5,381,563.60), Tolga Tanguler ($1,320,287.40), and Yvonne Greenstreet ($2,235,796.30). How much insider selling is happening at Alnylam Pharmaceuticals? Insiders have sold a total of 109,739 Alnylam Pharmaceuticals shares in the last 24 months for a total of $20,424,448.76 sold. Which members of congress are trading Alnylam Pharmaceuticals? Josh Gottheimer (D-NJ) has bought shares of Alnylam Pharmaceuticals in the last year totaling $8,000. Josh Gottheimer (D-NJ) has sold shares totaling $16,000. More Insider Trading Tools from MarketBeat Related Companies: Royalty Pharma Insider Trades BeiGene Insider Trades Sarepta Therapeutics Insider Trades Catalent Insider Trades Elanco Animal Health Insider Trades Biogen Insider Trades Neurocrine Biosciences Insider Trades BioMarin Pharmaceutical Insider Trades Incyte Insider Trades United Therapeutics Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month This page (NASDAQ:ALNY) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alnylam Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.